Sana Biotechnology Inc

{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ null, null, null, 4.98, 26.25 ], "ebit_estimate": [ -183.33, -202.83, -239.46, -283.97, -286.11 ], "ebitda_estimate": [ -169.78, -184.46, -215.69, null, null ], "net_income_estimate": [ -177.99, -198.59, -231.48, -283.04, -283.52 ], "per_share_eps_estimate": [ -0.62, -0.6, -0.6, -0.69, -0.63 ], "eps_nri_estimate": [ -0.62, -0.59, -0.62, -0.69, -0.63 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 0.42, 0.4, 0.35, null, null ], "pretax_income_estimate": [ -180.97, -202.81, -233.23, -283.04, -283.37 ], "operating_cash_flow_per_share_estimate": [ -0.62, -0.45, -0.34, null, null ], "roa_estimate": [ -34.1, -31.6, -31, null, null ], "roe_estimate": [ -92.89, -67.12, -66.62, null, null ], "gross_margin_estimate": [ null, null, 65, 65, 65 ], "operating_cash_flow_estimate": [ -171.65, -123.2, -94.13, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": 12.63, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 13.38, "future_eps_nri_estimate_growth": 12.63, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -15.47, "future_roa_estimate_growth": 15.6, "future_roe_estimate_growth": 18.6, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 17.15 }

{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712", "202803" ], "revenue_estimate": [ null, null, null, null, null, null, null, null ], "ebit_estimate": [ -42.52, -43.16, -52.82, -47.44, -43.31, -49.93, -51.11, null ], "ebitda_estimate": [ -42.48, -42.87, -43.94, -50.74, null, null, null, null ], "net_income_estimate": [ -40.4, -41.23, -55.36, -42.35, -43.31, -49.93, -51.11, null ], "per_share_eps_estimate": [ -0.15, -0.14, -0.16, -0.14, -0.15, -0.16, -0.16, null ], "eps_nri_estimate": [ -0.15, -0.14, -0.16, -0.15, -0.15, -0.16, -0.16, -0.18 ], "dividend_estimate": [ null, null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null, null ], "pretax_income_estimate": [ -39.42, -40.3, -56.1, -42.35, -43.31, -49.93, -51.11, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null, null ], "roe_estimate": [ -193.12, -94.22, -71.03, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null, null ], "long_term_growth_rate_mean": 12.63, "long_term_revenue_growth_rate_mean": "0.00", "future_per_share_eps_estimate_growth": 13.38, "future_eps_nri_estimate_growth": 12.63, "future_revenue_estimate_growth": null, "future_ebit_estimate_growth": null, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": null, "future_pretax_income_estimate_growth": null, "future_book_value_per_share_estimate_growth": -15.47, "future_roa_estimate_growth": 15.6, "future_roe_estimate_growth": 18.6, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": 17.15 }